NAVER D2SF

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Defense tech · Jul 27, 2026

NAVER D2SF is NAVER’s startup investment organization, identified through official materials for ImpriMed and NdotLight.

Recorded funding activity

ImpriMed combines live-cell drug testing with clinical data. NdotLight generates simulation-ready 3D data, while F4GE structures factory information for industrial buyers. The organization retains its identity separately from NAVER Ventures and the parent.

Sources
Rounds participated in
1
Confirmed lead rounds
—
1 roles undisclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
—
0 disclosed · full round size, not this investor’s share

By stage

Seed1

By primary sector

Defense tech1

By country

South Korea1

Rounds

1 in this selection
F4GE

Standardizes Korean factory data to connect manufacturers with global defense and industrial buyers

Role not disclosed